Article Publish Status: FREE
Abstract Title:

Effect of fucoidan on the biotinidase kinetics in human hepatocellular carcinoma.

Abstract Source:

Anticancer Res. 2009 Apr ;29(4):1211-7. PMID: 19414366

Abstract Author(s):

Kou Hayakawa, Takeaki Nagamine

Article Affiliation:

3-35-31 Taishido, Setagaya-ku, Tokyo 157-8535, Japan. [email protected]


BACKGROUND: Hepatocellular carcinoma (HCC) is difficult to treat with anticancer drugs. Therefore, development of new drugs for HCC is required.

MATERIALS AND METHODS: The livers of 14 hepatoma patients accompanied by hepatitis B (2 cases) and hepatitis C (12 cases) were used. The biotinidase kinetics of HCC tissues were compared to those of the adjacent liver tissues of 13 liver cirrhosis (LC) and 1 chronic active hepatitis (CAH).

RESULTS: The Kip (the inhibition constant by biotin) of HCC tissues were consistently higher than those of LC (plus CAH) tissues: the Kip was 450+/-231 micromol/l in HCC tissues and 240+/-111 micromol/l in LC (plus CAH) tissues, p<0.001. This increase of Kip is considered to be due to an increase of biotin repulsion by biotinidase in the HCC tissues. Fucoidan, a sulfated poly-fucose, was found to decrease the Kip of biotinidase in HCC tissues, and conversely to increase it in LC tissues. Fucoidan was also found to decrease the Kip of the hepatoma HuH-6 cells.

CONCLUSION: These findings suggest that fucoidan has a potential therapeutic effect on HCC.

Study Type : Animal Study

Print Options

Key Research Topics

Sayer Ji
Founder of

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022, Journal Articles copyright of original owners, MeSH copyright NLM.